Sign in
Active, not recruitingPhase 1

Novel Transdermal Ketoprofen Gel Formulation for Knee Osteoarthritis

Key facts

Who runs it
New Valley University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
Phase
Phase 1
People taking part
40 people enrolled
Started
10 May 2025
Ended
Feb 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • ketoprofen
Record updated
6 January 2026

Who can take part

Age
45 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Patient diagnosed with osteoarthritis in knee by:; Full history taking Physical examination including (joint tenderness, swelling, crepitus and limitation of motion)

Who cannot take part

  • 1. Patients with dual diagnosis 2. Patients have skin lesion or dermatologic disease in the treatment area

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A single blind randomized controlled clinical study

The 2 groups in the trial

  • formulation armTreatment being tested

    new formulation of ketoprofen

    Treatment: ketoprofen

  • commercial productExisting treatment, for comparison

    positive control receiving commercial product

    Treatment: ketoprofen

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Novel Transdermal Ketoprofen Gel Formulation for Knee Osteoarthritis: Comprehensive In-Vitro and Clinical Assessment
Record updated
6 January 2026